Literature DB >> 23387761

2D∕3D registration algorithm for lung brachytherapy.

P S Zvonarev1, T J Farrell, R Hunter, M Wierzbicki, J E Hayward, R K Sur.   

Abstract

PURPOSE: A 2D∕3D registration algorithm is proposed for registering orthogonal x-ray images with a diagnostic CT volume for high dose rate (HDR) lung brachytherapy.
METHODS: The algorithm utilizes a rigid registration model based on a pixel∕voxel intensity matching approach. To achieve accurate registration, a robust similarity measure combining normalized mutual information, image gradient, and intensity difference was developed. The algorithm was validated using a simple body and anthropomorphic phantoms. Transfer catheters were placed inside the phantoms to simulate the unique image features observed during treatment. The algorithm sensitivity to various degrees of initial misregistration and to the presence of foreign objects, such as ECG leads, was evaluated.
RESULTS: The mean registration error was 2.2 and 1.9 mm for the simple body and anthropomorphic phantoms, respectively. The error was comparable to the interoperator catheter digitization error of 1.6 mm. Preliminary analysis of data acquired from four patients indicated a mean registration error of 4.2 mm.
CONCLUSIONS: Results obtained using the proposed algorithm are clinically acceptable especially considering the complications normally encountered when imaging during lung HDR brachytherapy.

Entities:  

Mesh:

Year:  2013        PMID: 23387761     DOI: 10.1118/1.4788663

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  2 in total

1.  Automatic landmark detection and mapping for 2D/3D registration with BoneNet.

Authors:  Van Nguyen; Luis F Alves Pereira; Zhihua Liang; Falk Mielke; Jeroen Van Houtte; Jan Sijbers; Jan De Beenhouwer
Journal:  Front Vet Sci       Date:  2022-08-18

2.  First clinical experience with a novel, mobile cone-beam CT system for treatment quality assurance in brachytherapy.

Authors:  Andre Karius; Vratislav Strnad; Michael Lotter; Stephan Kreppner; Christoph Bert
Journal:  Strahlenther Onkol       Date:  2022-03-12       Impact factor: 4.033

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.